Silencing cardiomyocyte TLR4 reduces injury following hypoxia (Q48961004)

17 February 2018

title

Silencing cardiomyocyte TLR4 reduces injury following hypoxia (English)

1 reference

17 February 2018

0 references

1 reference

Orna Avlas

1

1 reference

17 February 2018

Smadar Srara

2

1 reference

17 February 2018

Asher Shainberg

3

1 reference

17 February 2018

Dan Aravot

4

1 reference

17 February 2018

Edith Hochhauser

5

1 reference

17 February 2018

language of work or name

English

0 references

publication date

19 July 2016

1 reference

17 February 2018

Experimental Cell Research

published in

1 reference

17 February 2018

volume

348

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

115-122

1 reference

17 February 2018

Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor function and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Innate immunity and cardiomyocytes in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Harmful molecular mechanisms in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Sirtuin 6 protects the heart from hypoxic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

NF-kappaB action in sepsis: the innate immune system and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptors: new players in myocardial ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

Role of toll-like receptor-4 in lung ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.07.020

10.1016/J.YEXCR.2016.07.020

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018